Cargando…
Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1
Although it is known that Phenazine biosynthesis-like domain-containing protein (PBLD) expression is downregulated in hepatocellular carcinoma (HCC), its biological function is unclear. Additionally, no agents capable of upregulating PBLD exist. In the current study, the relationship between PBLD an...
Autores principales: | Wu, Jiansong, Niu, Qiang, Yuan, Jie, Xu, Xiaodan, Cao, Liuxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862430/ https://www.ncbi.nlm.nih.gov/pubmed/31777531 http://dx.doi.org/10.3892/etm.2019.8080 |
Ejemplares similares
-
lncRNA-CD160 decreases the immunity of CD8(+) T cells through epigenetic mechanisms in hepatitis B virus infection
por: Wu, Jiansong, et al.
Publicado: (2020) -
Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma
por: Li, Aimin, et al.
Publicado: (2015) -
PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells
por: Han, Lu, et al.
Publicado: (2022) -
Epithelial PBLD attenuates intestinal inflammatory response and improves intestinal barrier function by inhibiting NF-κB signaling
por: Chen, Shengbo, et al.
Publicado: (2021) -
SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition
por: Su, Xi, et al.
Publicado: (2022)